SJUTS DUSTIN S (Chief Commercial Officer) received a stock award from REVANCE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/4/2024ACC: 0001479290-24-000054
Officer· Chief Commercial Officer
Since Dec 2019
+22.11K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
22.11K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+22.11K
Price / share
—
Trade value
—
% of position
14.0%
2/29/2024
157.62K→179.73K
Total
Net shares
+22.11K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/29/2024 | A · Award | +22.11K | — | — | 14.0% | 157.62K | 179.73K |
| Total | +22.11K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported